Th17 and Treg cells in adolescents with Graves’ disease. Impact of treatment with methimazole on these cell subsets

References

• Hollowell, J. G., N. W. Staehling, W. D. Flanders, et al. 2002. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87: 489–499
   PubMed Web of Science ®Google Scholar
• Brent, G. A. 2008. Clinical practice. Graves’ disease. N. Engl. J. Med. 358: 2594–2605
   PubMed Web of Science ®Google Scholar
• Nauman, J., and A. Nauman. 1995. Graves disease: etiopathogenesis, clinics, treatment. Polish J. Endocrinol. 46: 3–8
   Google Scholar
• Rivkees, S. A. 2006. The treatment of Graves’ disease in children. J. Pediatr. Endocrinol. Metab. 19: 1095–1111
   PubMed Web of Science ®Google Scholar
• McLachlan, S. M., Y. Nagayama, P. N. Pichurin, et al. 2007. The link between Graves’ disease and Hashimoto’s thyroiditis: a role for regulatory T cells. Endocrinology. 148: 5724–5733
   PubMed Web of Science ®Google Scholar
• Mao, C., S. Wang, Y. Xiao, et al. 2011. Impairment of regulatory capacity of CD4 + CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J. Immunol. 186: 4734–4743
   PubMed Web of Science ®Google Scholar
• Glick, A. B., A. Wodzinski, P. Fu, et al. 2013. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 23: 871–878
   PubMed Web of Science ®Google Scholar
• Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299: 1057–1061
   PubMed Web of Science ®Google Scholar
• Schwartz, R. H. 2005. Natural regulatory T cells and self-tolerance. Nat. Immunol. 6: 327–330
   PubMed Web of Science ®Google Scholar
• Romagnani, S., E. Maggi, F. Liotta, et al. 2009. Properties and origin of human Th17 cells. Mol. Immunol. 47: 3–7
   PubMed Web of Science ®Google Scholar
• Bending, D., S. Newland, A. Krejcí, et al. 2011. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behaviour of Th17 cells. J. Immunol. 186: 3373–3382
   PubMed Web of Science ®Google Scholar
• Annunziato, F., L. Cosmi, V. Santarlasci, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849–1861
   PubMed Web of Science ®Google Scholar
• Cosmi, L., L. Maggi, V. Santarlasci, et al. 2010. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 125: 222–230
   PubMed Web of Science ®Google Scholar
• Pearce, S. H. S. 2004. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin. Endocrinol. 61: 589–594
   PubMed Web of Science ®Google Scholar
• Molnar, I. 2007. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves’ disease during methimazole therapy. Autoimmunity. 40: 31–37
   PubMed Web of Science ®Google Scholar
• Crescioli, C., L. Cosmi, E. Borgogni, et al. 2007. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes. J. Endocrinol. 195: 145–155
   PubMed Web of Science ®Google Scholar
• Antonelli, A., M. Rotondi, P. Fallahi, et al. 2006. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves’ disease, and modulation by methimazole therapy. Clin. Endocrinol. 64: 189–195
   PubMed Web of Science ®Google Scholar
• Boehmer von, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338–344
   PubMed Web of Science ®Google Scholar
• Du, W., Y. W. Shen, W. H. Lee, et al. 2013. Foxp3(+) Treg expanded from patients with established diabetes reduce helios expression while retaining normal function compared to healthy individuals. PLoS One. 8: e56209
   Google Scholar
• Chen, M., G. Chen, S. Deng, et al. 2012. IFN-β induces the proliferation of CD4 + CD25 + Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis. J. Neuroimmunol. 242: 39–46
   PubMed Web of Science ®Google Scholar
• Furuhashi, T., C. Saito, K. Torii, et al. 2013. Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis. PLoS One. 8: e54895
   PubMed Web of Science ®Google Scholar
• van Herwijnen, M. J., L. Wieten, R. van der Zee, et al. 2012. Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis. Proc. Natl. Acad. Sci. U S A. 109: 14134–14139
   PubMed Web of Science ®Google Scholar
• Pesce, B., L. Soto, F. Sabugo, et al. 2013. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clin. Exp. Immunol. 171: 237–242
   PubMed Web of Science ®Google Scholar
• Singh, T. P., M. P. Schön, K. Wallbrecht, et al. 2013. Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of Psoriasis. PLoS One. 8: e51752
   PubMed Web of Science ®Google Scholar
• Vargas-Lowy, D., P. Kivisäkk, R. Gandhi, et al. 2012. Increased Th17 response to myelin peptides in pediatric MS. Clin. Immunol. 146: 176–184
   PubMed Web of Science ®Google Scholar
• Murdaca, G., B. M. Colombo, and F. Puppo. 2011. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern. Emerg. Med. 6: 487–495
   PubMed Web of Science ®Google Scholar
• Zhou, J., M. Bi, C. Fan, et al. 2012. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves’ hyperthyroidism. Clin. Exp. Med. 12: 39–46
   PubMed Web of Science ®Google Scholar
• Pan, D., Y. H. Shin, G. Gopalakrishnan, et al. 2009. Regulatory T cells in Graves’ disease. Clin. Endocrinol. 71: 587–593
   PubMed Web of Science ®Google Scholar
• Bossowski, A., M. Moniuszko, M. Dąbrowska, et al. 2013. Lower proportions of CD4 + CD25(high) and CD4 + FoxP3, but not CD4 + CD25 + CD127(low) FoxP3(+)T cell levels in children with autoimmune thyroid diseases. Autoimmunity. 46: 222--230
   Google Scholar
• Weetman, A. P., N. Tandon, and B. P. Morgan. 1992. Antithyroid drugs and release of inflammatory mediators by complement-attracted thyroid cells. Lancet. 340: 633–666
   PubMed Web of Science ®Google Scholar
• McDonald, D. O., and S. H. Pearce. 2009. Thyroid peroxidase forms thionamide-sensitive homodimers: relevance for immunomodulation of thyroid autoimmunity. J. Mol. Med. (Berl). 87: 971–980
   PubMed Web of Science ®Google Scholar